SMH
RDHL

Sanders Morris Harris’s Redhill Biopharma RDHL Stock Holding History

Sanders Morris Harris’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-64
Closed -$289K – 190
2020
Q1 		$289K Buy
64
+16
+33% +$80.1K 0.28% 84
2019
Q4 		$289K Sell
48
-3
-6% -$19.2K 0.07% 228
2019
Q3 		$358K Hold
51
– – 0.09% 181
2019
Q2 		$330K Buy
+51
New +$393K 0.09% 198

Other funds holding RDHL

DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
SFS
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Sanders Morris Harris's RDHL Position: Q2 2020 in Review

Sanders Morris Harris sold out of Redhill Biopharma (RDHL) in Q2 2020, closing a stake of 64 shares — an estimated $289K sold.

Sanders Morris Harris first reported a position in RDHL in Q2 2019 and held it in 4 quarters. The position peaked at $358K in Q3 2019. 41 funds tracked by Wall St. Rank hold RDHL as of Q2 2020.

  • Sanders Morris Harris reported no remaining Redhill Biopharma position as of Q2 2020 after selling out during the quarter.
  • Sanders Morris Harris sold 64 Redhill Biopharma shares in Q2 2020, an estimated $289K.
  • Sanders Morris Harris first reported a position in Redhill Biopharma in Q2 2019 and held it in 4 quarters.
  • Sanders Morris Harris's Redhill Biopharma position peaked at $358K in Q3 2019.
  • 41 funds tracked by Wall St. Rank held Redhill Biopharma as of Q2 2020.

Based on Sanders Morris Harris's 13F filing for Q2 2020, filed 9 Jul 2020.